Trial record 1 of 4 for:    celiac disease AND Toronto
Previous Study | Return to List | Next Study

Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease

This study has been completed.
Information provided by:
Alba Therapeutics Identifier:
First received: June 25, 2007
Last updated: January 18, 2010
Last verified: January 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)